APO Research

APO RESEARCH · REPORT

Soluble Guanylate Cyclase

Selected research

Industry Growth & Trends

Global Soluble Guanylate Cyclase Industry Growth and Trends Forecast to 2032

Market perspective

The global Soluble Guanylate Cyclase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Soluble Guanylate Cyclase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Soluble Guanylate Cyclase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Soluble Guanylate Cyclase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Soluble Guanylate Cyclase include Bayer AG, Topadur Pharma AG, SynZyme Technologies LLC, NicOx SA, Ironwood Pharmaceuticals Inc and Boehringer Ingelheim GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Soluble Guanylate Cyclase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Soluble Guanylate Cyclase market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Soluble Guanylate Cyclase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Soluble Guanylate Cyclase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Soluble Guanylate Cyclase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Soluble Guanylate Cyclase Market by Company

Bayer AG

Topadur Pharma AG

SynZyme Technologies LLC

NicOx SA

Ironwood Pharmaceuticals Inc

Boehringer Ingelheim GmbH

Soluble Guanylate Cyclase Segment by Type

Hydroxyurea

IW-1701

BI-703704

BAY-1636183

Others

Soluble Guanylate Cyclase Segment by Application

Ophthalmology

Cardiovascular

Gastrointestinal

Metabolic Disorders

Others

Soluble Guanylate Cyclase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soluble Guanylate Cyclase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Soluble Guanylate Cyclase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soluble Guanylate Cyclase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Soluble Guanylate Cyclase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Soluble Guanylate Cyclase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hydroxyurea Table 2. Major Company of IW-1701 Table 3. Major Company of BI-703704 Table 4. Major Company of BAY-1636183 Table 5. Major Company of Others Table 6. Global Soluble Guanylate Cyclase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Soluble Guanylate Cyclase Sales by Type (2021-2026) & (W Units) Table 8. Global Soluble Guanylate Cyclase Sales Market Share in Volume by Type (2021-2026) Table 9. Global Soluble Guanylate Cyclase Sales by Type (2021-2026) & (US$ Million) Table 10. Global Soluble Guanylate Cyclase Sales Market Share in Value by Type (2021-2026) Table 11. Global Soluble Guanylate Cyclase Price by Type (2021-2026) & (US$/Unit) Table 12. Global Soluble Guanylate Cyclase Sales by Type (2027-2032) & (W Units) Table 13. Global Soluble Guanylate Cyclase Sales Market Share in Volume by Type (2027-2032) Table 14. Global Soluble Guanylate Cyclase Sales by Type (2027-2032) & (US$ Million) Table 15. Global Soluble Guanylate Cyclase Sales Market Share in Value by Type (2027-2032) Table 16. Global Soluble Guanylate Cyclase Price by Type (2027-2032) & (US$/Unit) Table 17. North America Soluble Guanylate Cyclase Sales by Type (2021-2026) & (W Units) Table 18. North America Soluble Guanylate Cyclase Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Soluble Guanylate Cyclase Sales by Type (2021-2026) & (W Units) Table 20. Europe Soluble Guanylate Cyclase Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Soluble Guanylate Cyclase Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Soluble Guanylate Cyclase Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Soluble Guanylate Cyclase Sales by Type (2021-2026) & (W Units) Table 24. Latin America Soluble Guanylate Cyclase Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Soluble Guanylate Cyclase Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Soluble Guanylate Cyclase Sales by Type (2021-2026) & (US$ Million) Table 27. Soluble Guanylate Cyclase Industry Trends Table 28. Soluble Guanylate Cyclase Industry Drivers Table 29. Soluble Guanylate Cyclase Industry Opportunities and Challenges Table 30. Soluble Guanylate Cyclase Industry Restraints Table 31. Global Soluble Guanylate Cyclase Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Soluble Guanylate Cyclase Revenue Market Share by Company (2021-2026) Table 33. Global Soluble Guanylate Cyclase Sales by Company (2021-2026) & (W Units) Table 34. Global Soluble Guanylate Cyclase Sales Share by Company (2021-2026) Table 35. Global Soluble Guanylate Cyclase Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Soluble Guanylate Cyclase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Soluble Guanylate Cyclase Major Company Production Sites and Headquarters Table 38. Global Soluble Guanylate Cyclase Company, Product Type & Application Table 39. Global Soluble Guanylate Cyclase Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Soluble Guanylate Cyclase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Soluble Guanylate Cyclase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Soluble Guanylate Cyclase Sales by Region (2021-2026) & (W Units) Table 44. Global Soluble Guanylate Cyclase Sales Market Share in Volume by Region (2021-2026) Table 45. Global Soluble Guanylate Cyclase Sales by Region (2021-2026) & (US$ Million) Table 46. Global Soluble Guanylate Cyclase Sales Market Share in Value by Region (2021-2026) Table 47. Global Soluble Guanylate Cyclase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Soluble Guanylate Cyclase Sales by Region (2027-2032) & (W Units) Table 49. Global Soluble Guanylate Cyclase Sales Market Share in Volume by Region (2027-2032) Table 50. Global Soluble Guanylate Cyclase Sales by Region (2027-2032) & (US$ Million) Table 51. Global Soluble Guanylate Cyclase Sales Market Share in Value by Region (2027-2032) Table 52. Global Soluble Guanylate Cyclase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Soluble Guanylate Cyclase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Soluble Guanylate Cyclase Sales by Application (2021-2026) & (W Units) Table 55. Global Soluble Guanylate Cyclase Sales Market Share in Volume by Application (2021-2026) Table 56. Global Soluble Guanylate Cyclase Sales by Application (2021-2026) & (US$ Million) Table 57. Global Soluble Guanylate Cyclase Sales Market Share in Value by Application (2021-2026) Table 58. Global Soluble Guanylate Cyclase Price by Application (2021-2026) & (US$/Unit) Table 59. Global Soluble Guanylate Cyclase Sales by Application (2027-2032) & (W Units) Table 60. Global Soluble Guanylate Cyclase Sales Market Share in Volume by Application (2027-2032) Table 61. Global Soluble Guanylate Cyclase Sales by Application (2027-2032) & (US$ Million) Table 62. Global Soluble Guanylate Cyclase Sales Market Share in Value by Application (2027-2032) Table 63. Global Soluble Guanylate Cyclase Price by Application (2027-2032) & (US$/Unit) Table 64. North America Soluble Guanylate Cyclase Sales by Application (2021-2026) & (W Units) Table 65. North America Soluble Guanylate Cyclase Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Soluble Guanylate Cyclase Sales by Application (2021-2026) & (W Units) Table 67. Europe Soluble Guanylate Cyclase Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Soluble Guanylate Cyclase Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Soluble Guanylate Cyclase Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Soluble Guanylate Cyclase Sales by Application (2021-2026) & (W Units) Table 71. Latin America Soluble Guanylate Cyclase Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Soluble Guanylate Cyclase Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Soluble Guanylate Cyclase Sales by Application (2021-2026) & (US$ Million) Table 74. Bayer AG Company Information Table 75. Bayer AG Business Overview Table 76. Bayer AG Soluble Guanylate Cyclase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Bayer AG Soluble Guanylate Cyclase Product Portfolio Table 78. Bayer AG Recent Development Table 79. Topadur Pharma AG Company Information Table 80. Topadur Pharma AG Business Overview Table 81. Topadur Pharma AG Soluble Guanylate Cyclase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Topadur Pharma AG Soluble Guanylate Cyclase Product Portfolio Table 83. Topadur Pharma AG Recent Development Table 84. SynZyme Technologies LLC Company Information Table 85. SynZyme Technologies LLC Business Overview Table 86. SynZyme Technologies LLC Soluble Guanylate Cyclase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. SynZyme Technologies LLC Soluble Guanylate Cyclase Product Portfolio Table 88. SynZyme Technologies LLC Recent Development Table 89. NicOx SA Company Information Table 90. NicOx SA Business Overview Table 91. NicOx SA Soluble Guanylate Cyclase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. NicOx SA Soluble Guanylate Cyclase Product Portfolio Table 93. NicOx SA Recent Development Table 94. Ironwood Pharmaceuticals Inc Company Information Table 95. Ironwood Pharmaceuticals Inc Business Overview Table 96. Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Product Portfolio Table 98. Ironwood Pharmaceuticals Inc Recent Development Table 99. Boehringer Ingelheim GmbH Company Information Table 100. Boehringer Ingelheim GmbH Business Overview Table 101. Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Product Portfolio Table 103. Boehringer Ingelheim GmbH Recent Development Table 104. North America Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 105. North America Soluble Guanylate Cyclase Sales by Country (2021-2026) & (W Units) Table 106. North America Soluble Guanylate Cyclase Sales Market Share by Country (2021-2026) Table 107. North America Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032) & (W Units) Table 108. North America Soluble Guanylate Cyclase Sales Market Share Forecast by Country (2027-2032) Table 109. North America Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. North America Soluble Guanylate Cyclase Market Size by Country (2021-2026) & (US$ Million) Table 111. North America Soluble Guanylate Cyclase Market Share by Country (2021-2026) Table 112. North America Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. North America Soluble Guanylate Cyclase Market Share Forecast by Country (2027-2032) Table 114. Europe Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 115. Europe Soluble Guanylate Cyclase Sales by Country (2021-2026) & (W Units) Table 116. Europe Soluble Guanylate Cyclase Sales Market Share by Country (2021-2026) Table 117. Europe Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032) & (W Units) Table 118. Europe Soluble Guanylate Cyclase Sales Market Share Forecast by Country (2027-2032) Table 119. Europe Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Europe Soluble Guanylate Cyclase Market Size by Country (2021-2026) & (US$ Million) Table 121. Europe Soluble Guanylate Cyclase Market Share by Country (2021-2026) Table 122. Europe Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Europe Soluble Guanylate Cyclase Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Soluble Guanylate Cyclase Sales by Country (2021-2026) & (W Units) Table 126. Asia-Pacific Soluble Guanylate Cyclase Sales Market Share by Country (2021-2026) Table 127. Asia-Pacific Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032) & (W Units) Table 128. Asia-Pacific Soluble Guanylate Cyclase Sales Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Soluble Guanylate Cyclase Market Size by Country (2021-2026) & (US$ Million) Table 131. Asia-Pacific Soluble Guanylate Cyclase Market Share by Country (2021-2026) Table 132. Asia-Pacific Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Asia-Pacific Soluble Guanylate Cyclase Market Share Forecast by Country (2027-2032) Table 134. Latin America Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 135. Latin America Soluble Guanylate Cyclase Sales by Country (2021-2026) & (W Units) Table 136. Latin America Soluble Guanylate Cyclase Sales Market Share by Country (2021-2026) Table 137. Latin America Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032) & (W Units) Table 138. Latin America Soluble Guanylate Cyclase Sales Market Share Forecast by Country (2027-2032) Table 139. Latin America Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Latin America Soluble Guanylate Cyclase Market Size by Country (2021-2026) & (US$ Million) Table 141. Latin America Soluble Guanylate Cyclase Market Share by Country (2021-2026) Table 142. Latin America Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Latin America Soluble Guanylate Cyclase Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Soluble Guanylate Cyclase Sales by Country (2021-2026) & (W Units) Table 146. Middle East and Africa Soluble Guanylate Cyclase Sales Market Share by Country (2021-2026) Table 147. Middle East and Africa Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032) & (W Units) Table 148. Middle East and Africa Soluble Guanylate Cyclase Sales Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Soluble Guanylate Cyclase Market Size by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Soluble Guanylate Cyclase Market Share by Country (2021-2026) Table 152. Middle East and Africa Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Middle East and Africa Soluble Guanylate Cyclase Market Share Forecast by Country (2027-2032) Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Soluble Guanylate Cyclase Distributors List Table 157. Soluble Guanylate Cyclase Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Soluble Guanylate Cyclase Image Figure 2. Global Soluble Guanylate Cyclase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Soluble Guanylate Cyclase Market Size (2021-2032) & (US$ Million) Figure 4. Global Soluble Guanylate Cyclase Sales (2021-2032) & (W Units) Figure 5. Hydroxyurea Image Figure 6. Global Hydroxyurea Sales YoY Growth (2021-2032) & (W Units) Figure 7. IW-1701 Image Figure 8. Global IW-1701 Sales YoY Growth (2021-2032) & (W Units) Figure 9. BI-703704 Image Figure 10. Global BI-703704 Sales YoY Growth (2021-2032) & (W Units) Figure 11. BAY-1636183 Image Figure 12. Global BAY-1636183 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Soluble Guanylate Cyclase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Soluble Guanylate Cyclase Market Share by Type 2025 VS 2032 Figure 17. North America Soluble Guanylate Cyclase Sales Market Share in Volume by Type in 2025 Figure 18. North America Soluble Guanylate Cyclase Sales Market Share in Value by Type in 2025 Figure 19. Europe Soluble Guanylate Cyclase Sales Market Share in Volume by Type in 2025 Figure 20. Europe Soluble Guanylate Cyclase Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Soluble Guanylate Cyclase Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Soluble Guanylate Cyclase Sales Market Share in Value by Type in 2025 Figure 23. Latin America Soluble Guanylate Cyclase Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Soluble Guanylate Cyclase Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Soluble Guanylate Cyclase Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Soluble Guanylate Cyclase Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Soluble Guanylate Cyclase Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Ophthalmology Image Figure 30. Global Ophthalmology Sales YoY Growth (2021-2032) & (W Units) Figure 31. Cardiovascular Image Figure 32. Global Cardiovascular Sales YoY Growth (2021-2032) & (W Units) Figure 33. Gastrointestinal Image Figure 34. Global Gastrointestinal Sales YoY Growth (2021-2032) & (W Units) Figure 35. Metabolic Disorders Image Figure 36. Global Metabolic Disorders Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Soluble Guanylate Cyclase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Soluble Guanylate Cyclase Market Share by Application 2025 VS 2032 Figure 41. North America Soluble Guanylate Cyclase Sales Market Share in Volume by Application in 2025 Figure 42. North America Soluble Guanylate Cyclase Sales Market Share in Value by Application in 2025 Figure 43. Europe Soluble Guanylate Cyclase Sales Market Share in Volume by Application in 2025 Figure 44. Europe Soluble Guanylate Cyclase Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Soluble Guanylate Cyclase Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Soluble Guanylate Cyclase Sales Market Share in Value by Application in 2025 Figure 47. Latin America Soluble Guanylate Cyclase Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Soluble Guanylate Cyclase Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Soluble Guanylate Cyclase Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Soluble Guanylate Cyclase Sales Market Share in Value by Application in 2025 Figure 51. North America Soluble Guanylate Cyclase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Soluble Guanylate Cyclase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Soluble Guanylate Cyclase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Soluble Guanylate Cyclase Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Soluble Guanylate Cyclase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Soluble Guanylate Cyclase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Soluble Guanylate Cyclase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Soluble Guanylate Cyclase Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Soluble Guanylate Cyclase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Soluble Guanylate Cyclase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Soluble Guanylate Cyclase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Soluble Guanylate Cyclase Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Soluble Guanylate Cyclase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Soluble Guanylate Cyclase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Soluble Guanylate Cyclase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Soluble Guanylate Cyclase Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Soluble Guanylate Cyclase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Soluble Guanylate Cyclase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Soluble Guanylate Cyclase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Soluble Guanylate Cyclase Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Soluble Guanylate Cyclase Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Soluble Guanylate Cyclase Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Hydroxyurea
  • IW-1701
  • BI-703704
  • BAY-1636183
  • Others
Applications
  • Ophthalmology
  • Cardiovascular
  • Gastrointestinal
  • Metabolic Disorders
  • Others
Companies covered
  • Bayer AG
  • Topadur Pharma AG
  • SynZyme Technologies LLC
  • NicOx SA
  • Ironwood Pharmaceuticals Inc
  • Boehringer Ingelheim GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Soluble Guanylate Cyclase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Soluble Guanylate Cyclase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Soluble Guanylate Cyclase Market by Type
  6. 1.3.1 Hydroxyurea
  7. 1.3.2 IW-1701
  8. 1.3.3 BI-703704
  9. 1.3.4 BAY-1636183
  10. 1.3.5 Others
  11. 1.4 Global Soluble Guanylate Cyclase Market Size by Type
  12. 1.4.1 Global Soluble Guanylate Cyclase Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Soluble Guanylate Cyclase Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Soluble Guanylate Cyclase Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Soluble Guanylate Cyclase Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Soluble Guanylate Cyclase Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Soluble Guanylate Cyclase Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Soluble Guanylate Cyclase Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Soluble Guanylate Cyclase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Soluble Guanylate Cyclase Industry Trends
  2. 2.2 Soluble Guanylate Cyclase Industry Drivers
  3. 2.3 Soluble Guanylate Cyclase Industry Opportunities and Challenges
  4. 2.4 Soluble Guanylate Cyclase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Soluble Guanylate Cyclase Revenue (2021-2026)
  2. 3.2 Global Top Players by Soluble Guanylate Cyclase Sales (2021-2026)
  3. 3.3 Global Top Players by Soluble Guanylate Cyclase Price (2021-2026)
  4. 3.4 Global Soluble Guanylate Cyclase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Soluble Guanylate Cyclase Major Company Production Sites & Headquarters
  6. 3.6 Global Soluble Guanylate Cyclase Company, Product Type & Application
  7. 3.7 Global Soluble Guanylate Cyclase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Soluble Guanylate Cyclase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Soluble Guanylate Cyclase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Soluble Guanylate Cyclase Tier 1, Tier 2, and Tier 3
4 Soluble Guanylate Cyclase Regional Status and Outlook
  1. 4.1 Global Soluble Guanylate Cyclase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Soluble Guanylate Cyclase Historic Market Size by Region
  3. 4.2.1 Global Soluble Guanylate Cyclase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Soluble Guanylate Cyclase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Soluble Guanylate Cyclase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Soluble Guanylate Cyclase Forecasted Market Size by Region
  7. 4.3.1 Global Soluble Guanylate Cyclase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Soluble Guanylate Cyclase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Soluble Guanylate Cyclase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Soluble Guanylate Cyclase by Application
  1. 5.1 Soluble Guanylate Cyclase Market by Application
  2. 5.1.1 Ophthalmology
  3. 5.1.2 Cardiovascular
  4. 5.1.3 Gastrointestinal
  5. 5.1.4 Metabolic Disorders
  6. 5.1.5 Others
  7. 5.2 Global Soluble Guanylate Cyclase Market Size by Application
  8. 5.2.1 Global Soluble Guanylate Cyclase Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Soluble Guanylate Cyclase Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Soluble Guanylate Cyclase Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Soluble Guanylate Cyclase Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Soluble Guanylate Cyclase Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Soluble Guanylate Cyclase Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Soluble Guanylate Cyclase Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Soluble Guanylate Cyclase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bayer AG
  2. 6.1.1 Bayer AG Company Information
  3. 6.1.2 Bayer AG Business Overview
  4. 6.1.3 Bayer AG Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer AG Soluble Guanylate Cyclase Product Portfolio
  6. 6.1.5 Bayer AG Recent Developments
  7. 6.2 Topadur Pharma AG
  8. 6.2.1 Topadur Pharma AG Company Information
  9. 6.2.2 Topadur Pharma AG Business Overview
  10. 6.2.3 Topadur Pharma AG Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Topadur Pharma AG Soluble Guanylate Cyclase Product Portfolio
  12. 6.2.5 Topadur Pharma AG Recent Developments
  13. 6.3 SynZyme Technologies LLC
  14. 6.3.1 SynZyme Technologies LLC Company Information
  15. 6.3.2 SynZyme Technologies LLC Business Overview
  16. 6.3.3 SynZyme Technologies LLC Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 SynZyme Technologies LLC Soluble Guanylate Cyclase Product Portfolio
  18. 6.3.5 SynZyme Technologies LLC Recent Developments
  19. 6.4 NicOx SA
  20. 6.4.1 NicOx SA Company Information
  21. 6.4.2 NicOx SA Business Overview
  22. 6.4.3 NicOx SA Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 NicOx SA Soluble Guanylate Cyclase Product Portfolio
  24. 6.4.5 NicOx SA Recent Developments
  25. 6.5 Ironwood Pharmaceuticals Inc
  26. 6.5.1 Ironwood Pharmaceuticals Inc Company Information
  27. 6.5.2 Ironwood Pharmaceuticals Inc Business Overview
  28. 6.5.3 Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Product Portfolio
  30. 6.5.5 Ironwood Pharmaceuticals Inc Recent Developments
  31. 6.6 Boehringer Ingelheim GmbH
  32. 6.6.1 Boehringer Ingelheim GmbH Company Information
  33. 6.6.2 Boehringer Ingelheim GmbH Business Overview
  34. 6.6.3 Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Product Portfolio
  36. 6.6.5 Boehringer Ingelheim GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Soluble Guanylate Cyclase Sales by Country
  2. 7.1.1 North America Soluble Guanylate Cyclase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Soluble Guanylate Cyclase Sales by Country (2021-2026)
  4. 7.1.3 North America Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Soluble Guanylate Cyclase Market Size by Country
  6. 7.2.1 North America Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Soluble Guanylate Cyclase Market Size by Country (2021-2026)
  8. 7.2.3 North America Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Soluble Guanylate Cyclase Sales by Country
  2. 8.1.1 Europe Soluble Guanylate Cyclase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Soluble Guanylate Cyclase Sales by Country (2021-2026)
  4. 8.1.3 Europe Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Soluble Guanylate Cyclase Market Size by Country
  6. 8.2.1 Europe Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Soluble Guanylate Cyclase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Soluble Guanylate Cyclase Sales by Country
  2. 9.1.1 Asia-Pacific Soluble Guanylate Cyclase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Soluble Guanylate Cyclase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Soluble Guanylate Cyclase Market Size by Country
  6. 9.2.1 Asia-Pacific Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Soluble Guanylate Cyclase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Soluble Guanylate Cyclase Sales by Country
  2. 10.1.1 South America Soluble Guanylate Cyclase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Soluble Guanylate Cyclase Sales by Country (2021-2026)
  4. 10.1.3 South America Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Soluble Guanylate Cyclase Market Size by Country
  6. 10.2.1 South America Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Soluble Guanylate Cyclase Market Size by Country (2021-2026)
  8. 10.2.3 South America Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Soluble Guanylate Cyclase Sales by Country
  2. 11.1.1 Middle East and Africa Soluble Guanylate Cyclase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Soluble Guanylate Cyclase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Soluble Guanylate Cyclase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Soluble Guanylate Cyclase Market Size by Country
  6. 11.2.1 Middle East and Africa Soluble Guanylate Cyclase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Soluble Guanylate Cyclase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Soluble Guanylate Cyclase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Soluble Guanylate Cyclase Value Chain Analysis
  2. 12.1.1 Soluble Guanylate Cyclase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Soluble Guanylate Cyclase Production Mode & Process
  7. 12.2 Soluble Guanylate Cyclase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Soluble Guanylate Cyclase Distributors
  10. 12.2.3 Soluble Guanylate Cyclase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research